GALILEOhealthy: Observation of Acute Cardiopulmonary Effects in Healthy Individuals Performing Cardiopulmonary Exercise Test (CPX) During Whole Body Vibration (WBV)

Sponsor
Klinikum der Universität Köln (Other)
Overall Status
Unknown status
CT.gov ID
NCT04162054
Collaborator
(none)
20
1
7
2.9

Study Details

Study Description

Brief Summary

Observational study to evaluate acute cardiopulmonary effects of oscillatory whole body vibration (WBV) on healthy individuals analysed in non-invasive cardiopulmonary exercise test (CPX).

Condition or Disease Intervention/Treatment Phase
  • Other: Observational study to evaluate acute cardiopulmonary effects of whole body vibration (WBV) on healthy individuals analysed in non-invasive cardiopulmonary exercise test (CPX).

Detailed Description

Oscillatory whole-body vibration (WBV) is a novel exercise modality, which is performed on a vibrating platform that moves in sinusoidal oscillations, and during which static and dynamic exercises can be performed. Rapid movements of the platform lead to muscle spindle reflexes, which result in reflectory contraction of muscle groups and thus promote gain of muscle strength and power. The most efficient vibration rate enhancing muscle function is assumed to be ∼20 Hz, leading to constant muscle contraction and anaerobic metabolism of the affected muscle fibres. As a consequence, lactate liberation serves as a stimulus for muscle gain.This methodology has been successfully utilised to enhance moving velocity, muscle power and strength in young athletes and chronic obstructive pulmonary disease though not been understood in all details. Therefore this investigation will help to evaluate acute cardiopulmonary effects of whole body vibration (WBV) on healthy individuals analysed in non-invasive cardiopulmonary exercise test (CPX).

Study Design

Study Type:
Observational
Anticipated Enrollment :
20 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Observation of Acute Cardiopulmonary Effects in Healthy Individuals Performing Cardiopulmonary Exercise Test (CPX) During Whole Body Vibration (WBV)
Anticipated Study Start Date :
Mar 1, 2020
Anticipated Primary Completion Date :
Sep 30, 2020
Anticipated Study Completion Date :
Sep 30, 2020

Outcome Measures

Primary Outcome Measures

  1. Peak VO2 in mililiter [one day]

    maximal Oxygen saturation

Secondary Outcome Measures

  1. Nadir Co2 at anaerobic threshold [one day]

    Nadir Co2 in mmHG

  2. anaerobic threshold (AT) [one day]

    AT in mililiter

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • healthy individuals planning on performing a WBV-Training

  • healthy individuals planning on performing a CPX

Exclusion Criteria:
  • exclusion to perform CPX

  • exclusion to perform WBV

Contacts and Locations

Locations

Site City State Country Postal Code
1 Spezialambulanz für pulmonale Hypertonie Uniklinik Köln Köln NRW Germany 50937

Sponsors and Collaborators

  • Klinikum der Universität Köln

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Felix Gerhardt, Dr. med., Klinikum der Universität Köln
ClinicalTrials.gov Identifier:
NCT04162054
Other Study ID Numbers:
  • 003
First Posted:
Nov 14, 2019
Last Update Posted:
Jan 23, 2020
Last Verified:
Jan 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 23, 2020